At last week's Human Genetics Society of Australia meeting in Freemantle, Bluegnome announced the latest release of its arrayCGH analysis and database software, Bluefuse Multi.
Rapid increases in both the resolution and number of microarrays being used in arrayCGH investigations are driving an explosion in the amount of data being generated in cytogenetics laboratories.
At the same time more detailed reporting of gene content and the increased awareness of benign copy number variation in the normal population is limiting both the speed and confidence with which samples may be reported.
The latest release of Bluefuse Multi addresses this problem by delivering fully automated data analysis with sophisticated visualisation and reporting of copy number imbalances.
'Central to Bluefuse Multi v2.0 is Decisiontrack, which visualises each imbalance against tracks of gene content and CNV frequency downloaded from the major online data sources,' said Nick Haan, chief executive of Bluegnome.
'Decisiontrack also summarises the extents and frequencies of all imbalances in the database to enable "click through" access to the phenotypes of samples sharing a common imbalance,' he added.
In order to ensure laboratory staff benefit from immediate access to all arrayCGH results, unlimited software licenses are provided free of charge with all Cytochips.
'Bluefuse Multi provides our customers with the software tools they require to fully exploit results generated in their own lab and in the wider scientific community in order to improve the quality and confidence of reporting,' said Tony Lialin, director of North American sales.
Bluefuse Multi is available for immediate download and demonstration.
